19556812

Source:http://linkedlifedata.com/resource/pubmed/id/19556812

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0205179, umls-concept:C0750952, umls-concept:C0879262
pubmed:issue	1
pubmed:dateCreated	2009-7-10
pubmed:abstractText	The aim of this study was to evaluate the efficacy and safety of single-agent S-1 in patients with advanced biliary tract cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0135054
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid, http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination), http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
pubmed:status	MEDLINE
pubmed:issn	1423-0232
pubmed:author	pubmed-author:ArizumiToshihikoT, pubmed-author:HiranoKenjiK, pubmed-author:IsayamaHiroyukiH, pubmed-author:ItoYukikoY, pubmed-author:KawabeTakaoT, pubmed-author:KogureHirofumiH, pubmed-author:MatsubaraSaburoS, pubmed-author:NakaiYousukeY, pubmed-author:OmataMasaoM, pubmed-author:SasahiraNaokiN, pubmed-author:SasakiTakashiT, pubmed-author:TadaMinoruM, pubmed-author:TogawaOsamuO, pubmed-author:TsujinoTakeshiT, pubmed-author:YagiokaHiroshiH, pubmed-author:YashimaYokoY
pubmed:copyrightInfo	Copyright 2009 S. Karger AG, Basel.
pubmed:issnType	Electronic
pubmed:volume	77
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	71-4
pubmed:meshHeading	pubmed-meshheading:19556812-Adenocarcinoma, pubmed-meshheading:19556812-Adult, pubmed-meshheading:19556812-Aged, pubmed-meshheading:19556812-Aged, 80 and over, pubmed-meshheading:19556812-Antimetabolites, Antineoplastic, pubmed-meshheading:19556812-Biliary Tract Neoplasms, pubmed-meshheading:19556812-Disease Progression, pubmed-meshheading:19556812-Drug Combinations, pubmed-meshheading:19556812-Feasibility Studies, pubmed-meshheading:19556812-Female, pubmed-meshheading:19556812-Follow-Up Studies, pubmed-meshheading:19556812-Humans, pubmed-meshheading:19556812-Male, pubmed-meshheading:19556812-Middle Aged, pubmed-meshheading:19556812-Neoplasm Recurrence, Local, pubmed-meshheading:19556812-Neoplasm Staging, pubmed-meshheading:19556812-Oxonic Acid, pubmed-meshheading:19556812-Prognosis, pubmed-meshheading:19556812-Prospective Studies, pubmed-meshheading:19556812-Survival Rate, pubmed-meshheading:19556812-Tegafur, pubmed-meshheading:19556812-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	S-1 monotherapy in patients with advanced biliary tract cancer.
pubmed:affiliation	Department of Gastroenterology, Faculty of Medicine, University of Tokyo, Tokyo, Japan. sasakit-tky@umin.ac.jp
pubmed:publicationType	Journal Article